Testosterone Nasal Gel Market
Testosterone Nasal Gel Market Study by Primary Hypogonadism and Hypogonadotropic Hypogonadism in 5mg and 10mg Dosage From 2024 to 2034
Analysis of Testosterone Nasal Gels Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Testosterone Nasal Gel Market Outlook (2024 to 2034)
As per a new study published by Fact.MR, the global testosterone nasal gel market is analyzed at US$ 145.36 million in 2024 and is forecasted to increase at a 7.7% CAGR to touch US$ 306.08 million by the end of 2034.
The market for testosterone nasal gel is growing due to the rising number of diagnoses of hypogonadism, or low testosterone levels. More individuals are seeking treatment for symptoms, such as exhaustion, decreased libido, and muscle weakness because of aging populations and lifestyle factors, including stress, poor food, and lack of exercise leading to lower testosterone levels.
The use of nasal gels as a therapy option is driven by the growing need for testosterone replacement medicines. An easy and non-invasive substitute for conventional testosterone treatments, including injections and transdermal patches is testosterone nasal gels.
Because it is easy to use and applied through the nasal mucosa, it does not require needles or patches, which improves patient adherence to treatment and makes the therapy appealing to people looking for a more straightforward approach.
Bioavailability and quick absorption of testosterone are improved by developments in nasal gel formulations. Because nasal gels are made to absorb through the nasal mucosa more quickly, they release testosterone gradually, resulting in more stable blood testosterone levels. Patient satisfaction and treatment efficacy are enhanced by this innovation.
The North American region is forecasted to account for 36.7% of the global market share in 2024 due to its established healthcare system and strong awareness of low testosterone levels. The requirement for testosterone replacement treatments is high in the United States, where a sizable section of the population has been diagnosed with hypogonadism.
Based on the distribution channel, sales from hospital pharmacies are estimated to reach US$ 66.68 million in 2024 because they are essential for treating complicated medical diseases, such as hypogonadism. For individuals who need expert advice and specialized therapy due to severe or confirmed testosterone shortages, hospitals are important points of care.
| Report Attribute | Detail |
|---|---|
| Testosterone Nasal Gel Market Size (2024E) | US$ 145.36 Million |
| Forecasted Market Value (2034F) | US$ 306.08 Million |
| Global Market Growth Rate (2024 to 2034) | 7.7% CAGR |
| North America Market Share (2024E) | 36.7% |
| East Asia Market Value (2024E) | US$ 24.94 Million |
| South Asia & Pacific Market Growth Rate (2024 to 2034) | 9.3% CAGR |
| Primary Hypogonadism Segment Value (2034F) | US$ 191.93 Million |
| 10mg Segment Value (2034F) | US$ 217.65 Million |
| Key Companies Profiled | Acerus Pharmaceuticals Corporation; Hyundai Pharm Co.; Endo Pharmaceuticals Inc.; AbbVie Inc.; Bristol-Myers Squibb; Aceto Corporation; Noven Pharmaceuticals, Inc.; Endo Pharmaceuticals |
The hormone testosterone is in charge of the development of male sex organs, male fertility, spermatogenesis, and secondary characteristics. Testosterone nasal gels are used for the treatment of conditions, such as hypogonadism. In this condition, the body does not make sufficient natural testosterone. The market is mainly driven by the prevalence of hypogonadism, new product launches, and collaborations among the players.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Driving Demand for Testosterone Nasal Gels?
For the treatment of hypogonadism and other conditions, including Klinefelter syndrome, testosterone replacement therapy is given. During this therapy, supplements containing testosterone are administrated.
The major factors driving the demand for testosterone nasal gels are the rise in the prevalence of hypogonadism, new product launches, and collaborations among the players. According to a report, Klinefelter syndrome is one of the most common chromosomal disorders in newborns resulting in 1 in every 500 - 1000 newborns.
The prevalence of hypogonadism is common among the older male population above 60 years of age. The increasing aging population also acts as a driver for the testosterone nasal gel market.
The advantages offered by the testosterone nasal gel over the injectable form are also huge. This includes a less invasive delivery method, self-administered medications, early-onset, and others. These advantages act as a driver for the market resulting in the surge in demand for testosterone nasal gels during the forecast period.
Regional Outlook for Testosterone Nasal Gels
The market is dominated by the North American region. This is due to the presence of the major player in the market. Natesto is the only FDA-approved testosterone nasal gel and is manufactured by Acerus Pharmaceuticals Corporation situated in Canada. To make sales globally, the company collaborates with other companies for marketing its product globally.
For instance, Acerus Pharmaceuticals Corporation in collaboration with Hyundai Pharm Co. launched Natesto in South Korea. Apart from this hypogonadism affects approximately 4 to 5 million males in the U.S. These factors are responsible for growth in this region.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Who are the Key Manufacturers and Suppliers of Testosterone Nasal Gels?
Some of the leading manufacturers operating in the testosterone nasal gels include
- Acerus Pharmaceuticals Corporation
- Hyundai Pharm Co.
- Endo Pharmaceuticals Inc.
- AbbVie Inc.
- Bristol-Myers Squibb
- Aceto Corporation
- Noven Pharmaceuticals, Inc.
- Endo Pharmaceuticals
Testosterone Nasal Gel Market Report Highlights:
- Detailed overview of the parent market
- Changing market dynamics in the industry
- In-depth market segmentation
- Historical, current, and projected market size in terms of volume and value
- Recent industry trends and developments
- Competitive landscape
- Strategies of key players and products offered
- Potential and niche segments, geographical regions exhibiting promising growth
- A neutral perspective on market performance
- Must-have information for market players to sustain and enhance their market footprint
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Segmentation of Testosterone Nasal Gel Market Research
-
By Indication :
- Primary Hypogonadism
- Hypogonadotropic Hypogonadism
-
By Dosage :
- 5mg
- 10mg
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- Mail Order Pharmacies
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Indication
- 6.2. Dosage
- 6.3. Distribution Channel
- 7. Global Market Analysis and Forecast, By Indication
- 7.1. Primary hypogonadism
- 7.2. Hypogonadotropic hypogonadism
- 8. Global Market Analysis and Forecast, By Dosage
- 8.1. 5mg
- 8.2. 10mg
- 9. Global Market Analysis and Forecast, By Distribution Channel
- 9.1. Hospital Pharmacies
- 9.2. Retail Pharmacies
- 9.3. Mail Order Pharmacies
- 10. Global Market Analysis and Forecast, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. MEA
- 11. North America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 16. South Asia & Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 17. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 18. Sales Forecast by Indication, Dosage, and Distribution Channel for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. Acerus Pharmaceuticals Corporation
- 20.2. Hyundai Pharm Co.
- 20.3. Endo Pharmaceuticals Inc.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Indication
Table 3: Global Market US$ Mn Forecast by Dosage
Table 4: Global Market US$ Mn Forecast by Distribution Channel
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Indication
Table 7: North America Market US$ Mn Forecast by Dosage
Table 8: North America Market US$ Mn Forecast by Distribution Channel
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Indication
Table 11: Latin America Market US$ Mn Forecast by Dosage
Table 12: Latin America Market US$ Mn Forecast by Distribution Channel
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Indication
Table 15: Western Europe Market US$ Mn Forecast by Dosage
Table 16: Western Europe Market US$ Mn Forecast by Distribution Channel
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Indication
Table 19: Eastern Europe Market US$ Mn Forecast by Dosage
Table 20: Eastern Europe Market US$ Mn Forecast by Distribution Channel
Table 21: East Asia Market US$ Mn Forecast by Country
Table 22: East Asia Market US$ Mn Forecast by Indication
Table 23: East Asia Market US$ Mn Forecast by Dosage
Table 24: East Asia Market US$ Mn Forecast by Distribution Channel
Table 25: South Asia & Pacific Market US$ Mn Forecast by Country
Table 26: South Asia & Pacific Market US$ Mn Forecast by Indication
Table 27: South Asia & Pacific Market US$ Mn Forecast by Dosage
Table 28: South Asia & Pacific Market US$ Mn Forecast by Distribution Channel
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Indication
Table 31: MEA Market US$ Mn Forecast by Dosage
Table 32: MEA Market US$ Mn Forecast by Distribution Channel
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 22: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 23: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 24: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 26: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 27: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 28: South Asia & Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Indication
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Dosage
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channel
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the growth outlook for the testosterone nasal gel market through 2034?
The testosterone nasal gel market will experience substantial growth with a CAGR of 7.7% during the forecast period.
Which factors are driving demand for the testosterone nasal gel market?
The factors driving demand for testosterone nasal gels are the rise in the prevalence of hypogonadism and new product launches.
Which region will dominate the testosterone nasal gel market by 2034?
The market is dominated by the North American region with the presence of some major companies.
Testosterone Nasal Gel Market